IL-1ra Dose-range Study for Moderate-to-severe TBI Patients

Clinical trial NCT02997371 · UNKNOWN

Trial details

NCT number: NCT02997371
Sponsor: Adel Helmy
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Traumatic Brain INjury

Start date: 2017-10-01
Primary completion: 2021-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.